Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline vs Dydrogesterone for Infertility in Endometriosis
NCT06560814Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cabergoline in endometriosis and infertility (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Pain reduction estimated by mean change on a Visual Analog Scale at 24 weeks, Percentage change in size of chocolate cyst at 24 weeks and 1 more. Started Jul 2020; status: completed.
02
Drugs
cabergoline
03
Conditions
endometriosisinfertility
Beyond the preview
Go deeper on NCT06560814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06560814.